Literature DB >> 14728492

QuickSilver clinical tracker - a risk-management approach.

Daniel T Rosenthal1, Henry Chueh.   

Abstract

While many guidelines strive to automate the high-granular clinical thought process, the resulting risk stratification is often a low-granular management class (i.e. low, medium or high risk). Furthermore, the "low hanging fruit" of guidelines is not in decision support, rather in the subsequent action tracking. Therefore, we believe that only a small amount of data is required to produce significant reminders. In our approach, the clinician risk-stratifies the patient and enters the guideline at the management level. We do not attempt to replicate the clinical thought process; rather we ask the question, "Now that you have decided, how can we help track your decisions?" A risk-management approach encapsulates salient guideline features and provides a framework for basic decision support and data tracking.

Entities:  

Mesh:

Year:  2003        PMID: 14728492      PMCID: PMC1479974     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  4 in total

1.  Improving primary care for patients with chronic illness.

Authors:  Thomas Bodenheimer; Edward H Wagner; Kevin Grumbach
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

2.  Long-term changes in compliance with clinical guidelines through computer-based reminders.

Authors:  M M Morgan; J Goodson; G O Barnett
Journal:  Proc AMIA Symp       Date:  1998

3.  Interventions that increase use of adult immunization and cancer screening services: a meta-analysis.

Authors:  Erin G Stone; Sally C Morton; Marlies E Hulscher; Margaret A Maglione; Elizabeth A Roth; Jeremy M Grimshaw; Brian S Mittman; Lisa V Rubenstein; Laurence Z Rubenstein; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2002-05-07       Impact factor: 25.391

4.  Automating complex guidelines for chronic disease: lessons learned.

Authors:  Saverio M Maviglia; Rita D Zielstorff; Marilyn Paterno; Jonathan M Teich; David W Bates; Gilad J Kuperman
Journal:  J Am Med Inform Assoc       Date:  2003 Mar-Apr       Impact factor: 4.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.